Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center
Clinical trials sponsored by Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center, explained in plain language.
-
Could a common antidote help stroke patients?
Disease control CompletedThis study tested whether giving N-Acetylcysteine (NAC) intravenously soon after an acute ischemic stroke could improve outcomes. Only 4 adults with moderate to severe stroke were enrolled. Researchers measured stroke severity and disability at 30 and 90 days. The trial is comple…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Which antibiotic wins for skin infections? study pits doxycycline against TMP-SMX
Disease control CompletedThis study compared two common antibiotics, doxycycline and TMP-SMX, for treating uncomplicated skin infections like boils and cellulitis. 269 people aged 9 to 85 took one of the drugs for 7 days. Researchers checked if the infection cleared up early, at the end of treatment, and…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Male birth control pill moves closer to reality
Disease control CompletedThis study tests a new male hormone pill, dimethandrolone undecanoate (DMAU), as a potential daily contraceptive for men. Researchers gave single and repeated doses to 100 healthy men aged 18-50 to check safety and how the drug works in the body. The goal is to develop a reliable…
Phase: PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Feeding less to prevent baby fat: small study tests simple fix
Prevention CompletedThis study tested whether reducing the amount of pumped breast milk or formula given to babies of overweight or obese mothers could prevent them from becoming overweight at 6 months old. Researchers enrolled 60 mothers and their infants, carefully measuring and limiting milk inta…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Nerve stimulation maintenance: monthly or as needed for bladder control?
Symptom relief CompletedThis study tested two ways of scheduling maintenance therapy for overactive bladder using percutaneous tibial nerve stimulation (PTNS). 37 women who had already completed 12 weekly PTNS sessions were assigned to either monthly treatments or sessions only when they felt they neede…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
At-Home bladder treatment could rival clinic visits
Symptom relief CompletedThis study looked at whether a home-based nerve stimulation treatment (TTNS) works as well as a clinic-based version (PTNS) for overactive bladder. About 70 patients from a county hospital tried one of the two treatments and reported their symptoms and satisfaction. The goal was …
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can a simple communication tool cut unnecessary ICU care?
Knowledge-focused CompletedThis study tested a new way for doctors and families to talk about ICU care for very sick patients with advanced illnesses. Instead of continuing treatments indefinitely, they used 'time-limited trials' — agreements to try treatments for a set period and then check if the patient…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Lack of sleep may trigger diabetes through hormone changes
Knowledge-focused CompletedThis study looked at how not getting enough sleep changes hormones like cortisol and testosterone, and whether that leads to insulin resistance—a key step toward type 2 diabetes. Forty healthy men aged 22-45 took part. Researchers used drugs to mimic or block these hormone change…
Phase: EARLY_PHASE1 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:43 UTC